{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T01:42:12Z","timestamp":1791769332579,"version":"4.3.4"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07445-8","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:53:00Z","timestamp":1764247980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Extracellular vesicles in multiple myeloma-bone marrow niche crosstalk: from cellular dialogue to clinical perspectives"],"prefix":"10.1186","volume":"24","author":[{"given":"Martina","family":"Forestiero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Zimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Puzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Malivindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica Antonia","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Vigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Bonofiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gelsomino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4969-0607","authenticated-orcid":false,"given":"Cinzia","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"7445_CR1","doi-asserted-by":"crossref","unstructured":"Forster S, Radpour R, Ochsenbein AF. Molecular and immunological mechanisms of clonal evolution in multiple myeloma. Front Immunol. 2023;14.","DOI":"10.3389\/fimmu.2023.1243997"},{"key":"7445_CR2","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/ajh.27422","volume":"99","author":"SV Rajkumar","year":"2024","unstructured":"Rajkumar SV. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2024;99:1802\u201324.","journal-title":"Am J Hematol"},{"key":"7445_CR3","first-page":"3","volume":"9","author":"SA Padala","year":"2021","unstructured":"Padala SA, Barsouk A, Barsouk A, Rawla P, Vakiti A, Kolhe R, et al. Epidemiology, staging, and management of multiple myeloma. Med Sci. 2021;9:3.","journal-title":"Med Sci"},{"key":"7445_CR4","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.1038\/s41598-024-65590-4","volume":"14","author":"DT Zhu","year":"2024","unstructured":"Zhu DT, Park A, Lai A, Zhang L, Attar H, Rebbeck TR. Multiple myeloma incidence and mortality trends in the United States, 1999\u20132020. Sci Rep. 2024;14:14564.","journal-title":"Sci Rep"},{"key":"7445_CR5","doi-asserted-by":"crossref","first-page":"9054","DOI":"10.4081\/hr.2020.9054","volume":"12","author":"N Bolli","year":"2020","unstructured":"Bolli N, Martinelli G, Cerchione C. The molecular pathogenesis of multiple myeloma. Hematol Rep. 2020;12:9054.","journal-title":"Hematol Rep"},{"key":"7445_CR6","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos M-V, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. The Lancet Oncol. 2014;15:e538\u201348.","journal-title":"The Lancet Oncol"},{"key":"7445_CR7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cancers13020217","volume":"13","author":"A Garc\u00eda-Ortiz","year":"2021","unstructured":"Garc\u00eda-Ortiz A, Rodr\u00edguez-Garc\u00eda Y, Encinas J, Maroto-Mart\u00edn E, Castellano E, Teixid\u00f3 J, et al. The role of tumor microenvironment in multiple myeloma development and progression. Cancers (Basel). 2021;13:217.","journal-title":"Cancers (basel)"},{"key":"7445_CR8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/leu.2009.65","volume":"23","author":"M Garayoa","year":"2009","unstructured":"Garayoa M, Garcia JL, Santamaria C, Garcia-Gomez A, Blanco JF, Pandiella A, et al. Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors. Leukemia. 2009;23:1515\u201327.","journal-title":"Leukemia"},{"key":"7445_CR9","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1016\/j.clml.2020.05.026","volume":"20","author":"M Ho","year":"2020","unstructured":"Ho M, Goh CY, Patel A, Staunton S, O\u2019Connor R, Godeau M, et al. Role of the bone marrow milieu in multiple myeloma progression and therapeutic resistance. Clin Lymphoma Myeloma Leuk. 2020;20:e752\u201368.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"7445_CR10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s13679-025-00644-w","volume":"14","author":"L Manna","year":"2025","unstructured":"Manna L, Gelsomino L, Martino EA, Gentile M, And\u00f2 S, Bonofiglio D, et al. Unraveling obesity and multiple myeloma: insights from epidemiology and molecular mechanisms. Curr Obes Rep. 2025;14:52.","journal-title":"Curr Obes Rep"},{"key":"7445_CR11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13045-022-01366-5","volume":"15","author":"K Beider","year":"2022","unstructured":"Beider K, Voevoda-Dimenshtein V, Zoabi A, Rosenberg E, Magen H, Ostrovsky O, et al. CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression. J Hematol Oncol. 2022;15:144.","journal-title":"J Hematol Oncol"},{"key":"7445_CR12","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.3390\/jcm11216491","volume":"11","author":"A Melaccio","year":"2022","unstructured":"Melaccio A, Reale A, Saltarella I, Desantis V, Lamanuzzi A, Cicco S, et al. Pathways of angiogenic and inflammatory cytokines in multiple myeloma: role in plasma cell clonal expansion and drug resistance. J Clin Med. 2022;11:6491.","journal-title":"J Clin Med"},{"key":"7445_CR13","doi-asserted-by":"crossref","first-page":"38927","DOI":"10.18632\/oncotarget.7792","volume":"7","author":"J Wang","year":"2016","unstructured":"Wang J, Faict S, Maes K, De Bruyne E, Van Valckenborgh E, Schots R, et al. Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma. Oncotarget. 2016;7:38927\u201345.","journal-title":"Oncotarget"},{"key":"7445_CR14","doi-asserted-by":"crossref","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13.","DOI":"10.1002\/jev2.12451"},{"key":"7445_CR15","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1038\/s41388-024-03182-2","volume":"43","author":"T Sakaue","year":"2024","unstructured":"Sakaue T, Dorayappan KDP, Zingarelli R, Khadraoui W, Anbalagan M, Wallbillich J, et al. Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and metformin. Oncogene. 2024;43:3586\u201397.","journal-title":"Oncogene"},{"key":"7445_CR16","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.3390\/ijms21165841","volume":"21","author":"G Augimeri","year":"2020","unstructured":"Augimeri G, La Camera G, Gelsomino L, Giordano C, Panza S, Sisci D, et al. Evidence for enhanced exosome production in Aromatase inhibitor-resistant breast cancer cells. Int J Mol Sci. 2020;21:5841.","journal-title":"Int J Mol Sci"},{"key":"7445_CR17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-023-01413-9","volume":"22","author":"L Gong","year":"2024","unstructured":"Gong L, Li G, Yi X, Han Q, Wu Q, Ying F, et al. Tumor-derived small extracellular vesicles facilitate omental metastasis of ovarian cancer by triggering activation of mesenchymal stem cells. Cell Commun Signal. 2024;22:47.","journal-title":"Cell Commun Signal"},{"key":"7445_CR18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2021.08.021","volume":"521","author":"G La Camera","year":"2021","unstructured":"La Camera G, Gelsomino L, Malivindi R, Barone I, Panza S, De Rose D, et al. Adipocyte-derived extracellular vesicles promote breast cancer cell malignancy through HIF-1\u03b1 activity. Cancer Lett. 2021;521:155\u201368.","journal-title":"Cancer Lett"},{"key":"7445_CR19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12967-023-04075-w","volume":"21","author":"I Barone","year":"2023","unstructured":"Barone I, Gelsomino L, Accattatis FM, Giordano F, Gyorffy B, Panza S, et al. Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for let-7a. J Transl Med. 2023;21:232.","journal-title":"J Transl Med"},{"key":"7445_CR20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7150\/thno.87329","volume":"14","author":"SH Kang","year":"2024","unstructured":"Kang SH, Oh SY, Lee K-Y, Lee H-J, Kim M-S, Kwon T-G, et al. Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squamous cell carcinoma via miR-876-3p. Theranostics. 2024;14:460\u201379.","journal-title":"Theranostics"},{"key":"7445_CR21","doi-asserted-by":"crossref","first-page":"113526","DOI":"10.1016\/j.yexcr.2023.113526","volume":"425","author":"H Hu","year":"2023","unstructured":"Hu H, Jiang L, Kang X, Zhang L, Zeng S. Extracellular vesicles derived from lung cancer cells promote the progression of lung cancer by delivering miR-151a-5p. Exp Cell Res. 2023;425:113526.","journal-title":"Exp Cell Res"},{"key":"7445_CR22","doi-asserted-by":"crossref","first-page":"15695","DOI":"10.3390\/ijms242115695","volume":"24","author":"C Giordano","year":"2023","unstructured":"Giordano C, Accattatis FM, Gelsomino L, Del Console P, Gy\u0151rffy B, Giuliano M, et al. miRnas in the box: potential diagnostic role for extracellular vesicle-packaged miRNA-27a and miRNA-128 in breast cancer. Int J Mol Sci. 2023;24:15695.","journal-title":"Int J Mol Sci"},{"key":"7445_CR23","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.cmet.2023.04.013","volume":"35","author":"Z Wang","year":"2023","unstructured":"Wang Z, Kim SY, Tu W, Kim J, Xu A, Yang YM, et al. Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment. Cell Metab. 2023;35:1209\u201326.e13.","journal-title":"Cell Metab"},{"key":"7445_CR24","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.3390\/cells10113185","volume":"10","author":"I Saltarella","year":"2021","unstructured":"Saltarella I, Lamanuzzi A, Apollonio B, Desantis V, Bartoli G, Vacca A, et al. Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression. Cells. 2021;10:3185.","journal-title":"Cells"},{"key":"7445_CR25","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood.2021014749","volume":"140","author":"E Menu","year":"2022","unstructured":"Menu E, Vanderkerken K. Exosomes in multiple myeloma: from bench to bedside. Blood. 2022;140:2429\u201342.","journal-title":"Blood"},{"key":"7445_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/febs.70093","author":"C Wylie","year":"2025","unstructured":"Wylie C, Rowan R, Malinova D, Crawford L. Extracellular vesicles in multiple myeloma: pathogenesis and therapeutic application. The FEBS J. 2025. https:\/\/doi.org\/10.1111\/febs.70093.","journal-title":"The FEBS J"},{"key":"7445_CR27","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.3390\/ijms20133236","volume":"20","author":"M Colombo","year":"2019","unstructured":"Colombo M, Giannandrea D, Lesma E, Basile A, Chiaramonte R. Extracellular vesicles enhance multiple myeloma metastatic dissemination. Int J Mol Sci. 2019;20:3236.","journal-title":"Int J Mol Sci"},{"key":"7445_CR28","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI66517","volume":"123","author":"AM Roccaro","year":"2013","unstructured":"Roccaro AM, Sacco A, Maiso P, Azab AK, Tai Y-T, Reagan M, et al. Bm mesenchymal stromal cell\u2013derived exosomes facilitate multiple myeloma progression. J Clin Invest. 2013;123:1542\u201355.","journal-title":"J. Clin. Invest"},{"key":"7445_CR29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.20517\/evcna.2023.12","volume":"4","author":"D Gupta","year":"2023","unstructured":"Gupta D, Wiklander OP, Wood MJ, El-Andaloussi S. Biodistribution of therapeutic extracellular vesicles. Extracell Vesicles Circ Nucleic Acids. 2023;4:170\u201390.","journal-title":"Extracell Vesicles Circ Nucleic Acids"},{"key":"7445_CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","volume":"9","author":"MA Kumar","year":"2024","unstructured":"Kumar MA, Baba SK, Sadida HQ, Marzooqi SA, Jerobin J, Altemani FH, et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Target Ther. 2024;9:27.","journal-title":"Signal Transduct Target Ther"},{"key":"7445_CR31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/bioengineering9110675","volume":"9","author":"M de Almeida Fuzeta","year":"2022","unstructured":"de Almeida Fuzeta M, Gon\u00e7alves PP, Fernandes-Platzgummer A, Cabral JMS, Bernardes N, da Silva CL. From promise to reality: bioengineering strategies to enhance the therapeutic potential of extracellular vesicles. Bioengineering. 2022;9:675.","journal-title":"Bioengineering"},{"key":"7445_CR32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41580-023-00576-0","volume":"24","author":"AC Dixson","year":"2023","unstructured":"Dixson AC, Dawson TR, Di Vizio D, Weaver AM. Context-specific regulation of extracellular vesicle biogenesis and cargo selection. Nat Rev Mol Cell Biol. 2023;24:454\u201376.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7445_CR33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2016.09.017","volume":"98","author":"AM Silva","year":"2017","unstructured":"Silva AM, Teixeira JH, Almeida MI, Gon\u00e7alves RM, Barbosa MA, Santos SG. Extracellular vesicles: immunomodulatory messengers in the context of tissue repair\/regeneration. Eur J Pharm Sci. 2017;98:86\u201395.","journal-title":"Eur J Pharm Sci"},{"key":"7445_CR34","doi-asserted-by":"crossref","unstructured":"Ge X, Meng Q, Liu X, Shi S, Geng X, Wang E, et al. Extracellular vesicles from normal tissues orchestrate the homeostasis of macrophages and attenuate inflammatory injury of sepsis. Bioeng Transl Med. 2024;9.","DOI":"10.1002\/btm2.10609"},{"key":"7445_CR35","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.7150\/jca.98426","volume":"15","author":"R Mir","year":"2024","unstructured":"Mir R, Baba SK, Elfaki I, Algehainy N, Alanazi MA, Altemani FH, et al. Unlocking the secrets of extracellular vesicles: orchestrating tumor microenvironment dynamics in metastasis, drug resistance, and immune evasion. J Cancer. 2024;15:6383\u2013415.","journal-title":"J Cancer"},{"key":"7445_CR36","doi-asserted-by":"crossref","unstructured":"Liu X, Kkw T, Zeng Q, Fu L. Effect of extracellular vesicles derived from tumor cells on immune evasion. Adv Sci. 2025;12.","DOI":"10.1002\/advs.202417357"},{"key":"7445_CR37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12964-023-01408-6","volume":"22","author":"K H\u00e1n\u011blov\u00e1","year":"2024","unstructured":"H\u00e1n\u011blov\u00e1 K, Raudensk\u00e1 M, Masa\u0159\u00edk M, Balvan J. Protein cargo in extracellular vesicles as the key mediator in the progression of cancer. Cell Commun Signal. 2024;22:25.","journal-title":"Cell Commun Signal"},{"key":"7445_CR38","doi-asserted-by":"crossref","unstructured":"Yang Q, Xu J, Gu J, Shi H, Zhang J, Zhang J, et al. Extracellular vesicles in cancer drug resistance: roles, mechanisms, and implications. Adv Sci. 2022;9.","DOI":"10.1002\/advs.202201609"},{"key":"7445_CR39","doi-asserted-by":"crossref","unstructured":"Zuo J, Yan H, Qin S, Yan Y, Wang S, Yang L, et al. Extracellular vesicles in cancer drug resistance: mechanistic insights and therapeutic implications. Medcomm \u2013 Oncol. 2024;3.","DOI":"10.1002\/mog2.94"},{"key":"7445_CR40","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/biomedicines9081061","volume":"9","author":"MI Mosquera-Heredia","year":"2021","unstructured":"Mosquera-Heredia MI, Morales LC, Vidal OM, Barcel\u00f3 E, Silvera-Redondo C, V\u00e9lez JI, et al. Exosomes: potential disease biomarkers and New Therapeutic targets. Biomedicines. 2021;9:1061.","journal-title":"Biomedicines"},{"key":"7445_CR41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40364-023-00540-2","volume":"11","author":"K Asleh","year":"2023","unstructured":"Asleh K, Dery V, Taylor C, Davey M, Djeungoue-Petga M-A, Ouellette RJ. Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology. Biomark Res. 2023;11:99.","journal-title":"Biomark Res"},{"key":"7445_CR42","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1038\/ncomms8439","volume":"6","author":"GK Atkin-Smith","year":"2015","unstructured":"Atkin-Smith GK, Tixeira R, Paone S, Mathivanan S, Collins C, Liem M, et al. A novel mechanism of generating extracellular vesicles during apoptosis via a beads-on-a-string membrane structure. Nat Commun. 2015;6:7439.","journal-title":"Nat Commun"},{"key":"7445_CR43","doi-asserted-by":"crossref","first-page":"80\u2013","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:80\u2013.","journal-title":"Science"},{"key":"7445_CR44","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.2147\/IJN.S310357","volume":"16","author":"S Gurunathan","year":"2021","unstructured":"Gurunathan S, Kang M-H, Qasim M, Khan K, Biogenesis KJ-H. Membrane trafficking, functions, and next generation nanotherapeutics medicine of extracellular vesicles. Int J Nanomed. 2021;16:3357\u201383.","journal-title":"Int J Nanomed"},{"key":"7445_CR45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1096\/fba.2020-00127","volume":"3","author":"JW Clancy","year":"2021","unstructured":"Clancy JW, Schmidtmann M, D\u2019Souza-Schorey C. The ins and outs of microvesicles. FASEB Bioadv. 2021;3:399\u2013406.","journal-title":"FASEB Bioadv"},{"key":"7445_CR46","doi-asserted-by":"crossref","unstructured":"Wiklander OPB, Brennan M\u00c1, L\u00f6tvall J, Breakefield XO, Andaloussi EL, S. Advances in therapeutic applications of extracellular vesicles. Sci Transl Med. 2019;11.","DOI":"10.1126\/scitranslmed.aav8521"},{"key":"7445_CR47","doi-asserted-by":"publisher","DOI":"10.20517\/evcna.2021.07","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Wijerathne H, Godwin AK, Soper SA. Isolation and analysis methods of extracellular vesicles (EVs). Extracell Vesicles Circ Nucleic Acids. 2021. https:\/\/doi.org\/10.20517\/evcna.2021.07.","journal-title":"Extracell Vesicles Circ Nucleic Acids"},{"key":"7445_CR48","doi-asserted-by":"crossref","unstructured":"Xu X, Lai Y, Hua Z-C. Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep. 2019;39.","DOI":"10.1042\/BSR20180992"},{"key":"7445_CR49","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.3390\/cancers14225575","volume":"14","author":"J Iskrzak","year":"2022","unstructured":"Iskrzak J, Zygmunciak P, Misiewicz-Krzemi\u0144ska I, Pu\u0142a B. Extracellular vesicles in multiple myeloma\u2014cracking the code to a better understanding of the disease. Cancers (Basel). 2022;14:5575.","journal-title":"Cancers (basel)"},{"key":"7445_CR50","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.3390\/cells10112865","volume":"10","author":"A Allegra","year":"2021","unstructured":"Allegra A, Di Gioacchino M, Tonacci A, Petrarca C, Musolino C, Gangemi S. Multiple myeloma cell-derived Exosomes: implications on Tumorigenesis, diagnosis, prognosis and therapeutic strategies. Cells. 2021;10:2865.","journal-title":"Cells"},{"key":"7445_CR51","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3324\/haematol.2021.279716","volume":"107","author":"D Giannandrea","year":"2022","unstructured":"Giannandrea D, Platonova N, Colombo M, Mazzola M, Citro V, Adami R, et al. Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a notch dependent way. Haematologica. 2022;107:2183\u201394.","journal-title":"Haematologica"},{"key":"7445_CR52","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/path.4712","volume":"239","author":"J Wang","year":"2016","unstructured":"Wang J, De Veirman K, Faict S, Frassanito MA, Ribatti D, Vacca A, et al. Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression. The J Pathol. 2016;239:162\u201373.","journal-title":"The J Pathol"},{"key":"7445_CR53","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1038\/s41388-019-0788-4","volume":"38","author":"B Li","year":"2019","unstructured":"Li B, Hong J, Hong M, Wang Y, Yu T, Zang S, et al. piRNA-823 delivered by multiple myeloma-derived extracellular vesicles promoted tumorigenesis through re-educating endothelial cells in the tumor environment. Oncogene. 2019;38:5227\u201338.","journal-title":"Oncogene"},{"key":"7445_CR54","doi-asserted-by":"crossref","first-page":"113862","DOI":"10.1016\/j.intimp.2024.113862","volume":"146","author":"Y Fu","year":"2025","unstructured":"Fu Y, Sang J, Zhang F, Jiang S, Li F, Liang T, et al. Exosomal tRF-1003 induces angiogenesis via regulating the HIF1\u03b1\/VEGF signaling in multiple myeloma. Int Immunopharmacol. 2025;146:113862.","journal-title":"Int Immunopharmacol"},{"key":"7445_CR55","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1182\/blood-2014-05-576116","volume":"124","author":"T Umezu","year":"2014","unstructured":"Umezu T, Tadokoro H, Azuma K, Yoshizawa S, Ohyashiki K, Ohyashiki JH. Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014;124:3748\u201357.","journal-title":"Blood"},{"key":"7445_CR56","first-page":"1","volume":"2017","author":"Q Cheng","year":"2017","unstructured":"Cheng Q, Li X, Liu J, Ye Q, Chen Y, Tan S, et al. Multiple myeloma-derived Exosomes regulate the functions of mesenchymal stem cells partially via modulating miR-21 and miR-146a. STEM Cells Int. 2017;2017:1\u20139.","journal-title":"STEM Cells Int"},{"key":"7445_CR57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2016.04.024","volume":"377","author":"K De Veirman","year":"2016","unstructured":"De Veirman K, Wang J, Xu S, Leleu X, Himpe E, Maes K, et al. Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity. Cancer Lett. 2016;377:17\u201324.","journal-title":"Cancer Lett"},{"key":"7445_CR58","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.3390\/ijms24076862","volume":"24","author":"E Vulpis","year":"2023","unstructured":"Vulpis E, Cuollo L, Borrelli C, Antonangeli F, Masuelli L, Cippitelli M, et al. Doxorubicin\u2013mediated miR\u2013433 expression on exosomes promotes bystander senescence in multiple myeloma cells in a DDR\u2013Independent manner. Int J Mol Sci. 2023;24:6862.","journal-title":"Int J Mol Sci"},{"key":"7445_CR59","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/s42003-024-06918-8","volume":"7","author":"M Yu","year":"2024","unstructured":"Yu M, Cai Z, Zhang J, Zhang Y, Fu J, Cui X. Aberrant NSUN2-mediated m5C modification of exosomal LncRNA MALAT1 induced RANKL-mediated bone destruction in multiple myeloma. Commun Biol. 2024;7:1249.","journal-title":"Commun Biol"},{"key":"7445_CR60","doi-asserted-by":"crossref","first-page":"113080","DOI":"10.1016\/j.intimp.2024.113080","volume":"142","author":"Y Song","year":"2024","unstructured":"Song Y, Guo N, Zi F, Zheng J, Cheng J. lncRNA H19 plays a role in multiple myeloma via interacting with hnRNPA2B1 to stabilize bet proteins by targeting osteoclasts and osteoblasts. Int Immunopharmacol. 2024;142:113080.","journal-title":"Int Immunopharmacol"},{"key":"7445_CR61","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13045-018-0689-y","volume":"12","author":"S Raimondo","year":"2019","unstructured":"Raimondo S, Saieva L, Vicario E, Pucci M, Toscani D, Manno M, et al. Multiple myeloma-derived exosomes are enriched of amphiregulin (areg) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis. J Hematol Oncol. 2019;12:2.","journal-title":"J Hematol Oncol"},{"key":"7445_CR62","doi-asserted-by":"crossref","unstructured":"Deng Z, Sun S, Zhou N, Peng Y, Cheng L, Yu X, et al. PNPO-mediated oxidation of DVL3 promotes multiple myeloma malignancy and osteoclastogenesis by activating the Wnt\/\u03b2-catenin pathway. Adv Sci. 2025;12.","DOI":"10.1002\/advs.202407681"},{"key":"7445_CR63","doi-asserted-by":"crossref","unstructured":"Vulpis E, Loconte L, Peri A, Molfetta R, Caracciolo G, Masuelli L, et al. Impact on nk cell functions of acute versus chronic exposure to extracellular vesicle-associated mica: dual role in cancer immunosurveillance. J Extracell Vesicles. 2022;11.","DOI":"10.1002\/jev2.12176"},{"key":"7445_CR64","doi-asserted-by":"crossref","first-page":"9467","DOI":"10.3390\/ijms24119467","volume":"24","author":"E Vulpis","year":"2023","unstructured":"Vulpis E, Loconte L, Cassone C, Antonangeli F, Caracciolo G, Masuelli L, et al. Cross-dressing of multiple myeloma cells mediated by extracellular vesicles conveying MIC and ULBP ligands promotes nk cell killing. Int J Mol Sci. 2023;24:9467.","journal-title":"Int J Mol Sci"},{"key":"7445_CR65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/1541-7786.MCR-23-0282","volume":"22","author":"Q-M Wang","year":"2024","unstructured":"Wang Q-M, Lian G-Y, Sheng S-M, Xu J, Ye L-L, Min C, et al. Exosomal lncRNA NEAT1 inhibits NK-Cell activity to promote multiple myeloma cell immune escape via an EZH2\/PBX1 Axis. Mol Cancer Res. 2024;22:125\u201336.","journal-title":"Mol Cancer Res"},{"key":"7445_CR66","doi-asserted-by":"crossref","unstructured":"Lopes R, Caetano J, Barahona F, Pestana C, Ferreira BV, Louren\u00e7o D, et al. Multiple myeloma-derived extracellular vesicles modulate the bone marrow immune microenvironment. Front Immunol. 2022;13.","DOI":"10.3389\/fimmu.2022.909880"},{"key":"7445_CR67","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/apm.13306","volume":"131","author":"B Razi","year":"2023","unstructured":"Razi B, Soleimani M, Soufi-Zomorrod M, Adeli A, Davoudi N. Multiple myeloma cell-derived exosomes promote favorable tumor functional performance by polarizing macrophages toward M2-like cells. APMIS. 2023;131:381\u201393.","journal-title":"APMIS"},{"key":"7445_CR68","doi-asserted-by":"crossref","first-page":"12118","DOI":"10.3390\/ijms222212118","volume":"22","author":"M Pucci","year":"2021","unstructured":"Pucci M, Raimondo S, Urz\u00ec O, Moschetti M, Di Bella MA, Conigliaro A, et al. Tumor-derived small extracellular vesicles induce Pro-inflammatory Cytokine expression and PD-L1 regulation in M0 macrophages via IL-6\/STAT3 and TLR4 signaling pathways. Int J Mol Sci. 2021;22:12118.","journal-title":"Int J Mol Sci"},{"key":"7445_CR69","doi-asserted-by":"crossref","first-page":"167457","DOI":"10.1016\/j.bbadis.2024.167457","volume":"1870","author":"X Chen","year":"2024","unstructured":"Chen X, Wang L, Cheng Q, Deng Z, Tang Y, Yan Y, et al. Multiple myeloma exosomal miRnas suppress cGAS-STING antiviral immunity. Biochim Biophys Acta - Mol Basis Dis. 2024;1870:167457.","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"7445_CR70","doi-asserted-by":"crossref","unstructured":"Mizuhara K, Shimura Y, Tsukamoto T, Kanai A, Kuwahara-Ota S, Yamaguchi J, et al. Tumour-derived exosomes promote the induction of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells by delivering miR -106a-5p and miR -146a-5p in multiple myeloma. Br J Haematol. 2023;203:426\u201338.","DOI":"10.1111\/bjh.19049"},{"key":"7445_CR71","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.matbio.2017.09.001","volume":"65","author":"SK Bandari","year":"2018","unstructured":"Bandari SK, Purushothaman A, Ramani VC, Brinkley GJ, Chandrashekar DS, Varambally S, et al. Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biol. 2018;65:104\u201318.","journal-title":"Matrix Biol"},{"key":"7445_CR72","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/OTT.S286751","volume":"14","author":"DM Rodrigues-Junior","year":"2021","unstructured":"Rodrigues-Junior DM, de A PM, Nader HB, Vettore AL, Pinhal MAS. MicroRNA-1252-5p associated with extracellular vesicles enhances bortezomib sensitivity in multiple myeloma cells by targeting heparanase. Onco Targets Ther. 2021;14:455\u201367.","journal-title":"Onco Targets Ther"},{"key":"7445_CR73","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3390\/cancers11121823","volume":"11","author":"S Faict","year":"2019","unstructured":"Faict S, Oudaert I, D\u2019Auria L, Dehairs J, Maes K, Vlummens P, et al. The transfer of sphingomyelinase contributes to drug resistance in multiple myeloma. Cancers (Basel). 2019;11:1823.","journal-title":"Cancers (Basel)"},{"key":"7445_CR74","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12964-025-02158-3","volume":"23","author":"M Shi","year":"2025","unstructured":"Shi M, Shen N, Liu X, Yu J, Shen X, Chen Y, et al. Exosome-transmitted HSPA9 facilitates bortezomib resistance by targeting TRIP13\/USP1 signaling in multiple myeloma. Cell Commun Signal. 2025;23:152.","journal-title":"Cell Commun Signal"},{"key":"7445_CR75","doi-asserted-by":"crossref","first-page":"30876","DOI":"10.18632\/oncotarget.9021","volume":"7","author":"L Zhang","year":"2016","unstructured":"Zhang L, Pan L, Xiang B, Zhu H, Wu Y, Chen M, et al. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma. Oncotarget. 2016;7:30876\u201391.","journal-title":"Oncotarget"},{"key":"7445_CR76","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4274\/tjh.galenos.2020.2020.0243","volume":"37","author":"Y Luo","year":"2020","unstructured":"Luo Y, Gui R. Circulating exosomal CircMYC is associated with recurrence and Bortezomib Resistance in patients with multiple myeloma. Turk J Hematol. 2020;37:248\u201355.","journal-title":"Turk J Hematol"},{"key":"7445_CR77","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1158\/1078-0432.CCR-23-4097","volume":"30","author":"C Massaro","year":"2024","unstructured":"Massaro C, Sensoy HN, Mulders M, De Schrijver C, G\u00f3mez-Mart\u00edn C, Simon Nieto J, et al. Tumor-secreted extracellular vesicles counteract therapy response by triggering inflammatory mesenchymal stem cell development. Clin Cancer Res. 2024;30:4714\u201328.","journal-title":"Clin Cancer Res"},{"key":"7445_CR78","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.3390\/cells11213365","volume":"11","author":"K Brennan","year":"2022","unstructured":"Brennan K, Iversen KF, Blanco-Fern\u00e1ndez A, Lund T, Plesner T, Mc Gee MM. Extracellular vesicles isolated from plasma of multiple myeloma patients treated with daratumumab express CD38, PD-L1, and the complement inhibitory proteins CD55 and CD59. Cells. 2022;11:3365.","journal-title":"Cells"},{"key":"7445_CR79","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1182\/bloodadvances.2019000403","volume":"3","author":"T Umezu","year":"2019","unstructured":"Umezu T, Imanishi S, Yoshizawa S, Kawana C, Ohyashiki JH, Ohyashiki K. Induction of multiple myeloma bone marrow stromal cell apoptosis by inhibiting extracellular vesicle miR-10a secretion. Blood Adv. 2019;3:3228\u201340.","journal-title":"Blood Adv"},{"key":"7445_CR80","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jcyt.2018.10.006","volume":"21","author":"M Deng","year":"2019","unstructured":"Deng M, Yuan H, Liu S, Hu Z, Xiao H. Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA\/BCL-2 expression. Cytotherapy. 2019;21:96\u2013106.","journal-title":"Cytotherapy"},{"key":"7445_CR81","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/bloodadvances.2016003251","volume":"1","author":"T Umezu","year":"2017","unstructured":"Umezu T, Imanishi S, Azuma K, Kobayashi C, Yoshizawa S, Ohyashiki K, et al. Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis. Blood Adv. 2017;1:812\u201323.","journal-title":"Blood Adv"},{"key":"7445_CR82","doi-asserted-by":"crossref","first-page":"43992","DOI":"10.18632\/oncotarget.6083","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang J, De Veirman K, De Beule N, Maes K, De Bruyne E, Van Valckenborgh E, et al. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells. Oncotarget. 2015;6:43992\u20134004.","journal-title":"Oncotarget"},{"key":"7445_CR83","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood-2014-03-562439","volume":"124","author":"J Wang","year":"2014","unstructured":"Wang J, Hendrix A, Hernot S, Lemaire M, De Bruyne E, Van Valckenborgh E, et al. Bone marrow stromal cell\u2013derived exosomes as communicators in drug resistance in multiple myeloma cells. Blood. 2014;124:555\u201366.","journal-title":"Blood"},{"key":"7445_CR84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1158\/0008-5472.CAN-23-0189","volume":"84","author":"H Zhang","year":"2024","unstructured":"Zhang H, Du Z, Tu C, Zhou X, Menu E, Wang J. Hypoxic bone marrow stromal cells secrete miR-140\u20135p and miR-28\u20133p that target SPRED1 to confer drug resistance in multiple myeloma. Cancer Res. 2024;84:39\u201355.","journal-title":"Cancer Res"},{"key":"7445_CR85","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/carcin\/bgz169","volume":"41","author":"M Dabbah","year":"2020","unstructured":"Dabbah M, Jarchowsky-Dolberg O, Attar-Schneider O, Tartakover Matalon S, Pasmanik-Chor M, Drucker L, et al. Multiple myeloma BM-MSCs increase the tumorigenicity of mm cells via transfer of VLA4-enriched microvesicles. Carcinogenesis. 2020;41:100\u201310.","journal-title":"Carcinogenesis"},{"key":"7445_CR86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trsl.2021.04.002","volume":"236","author":"M Dabbah","year":"2021","unstructured":"Dabbah M, Lishner M, Jarchowsky-Dolberg O, Tartakover-Matalon S, Brin YS, Pasmanik-Chor M, et al. Ribosomal proteins as distinct \u201cpassengers\u201d of microvesicles: new semantics in myeloma and mesenchymal stem cells\u2019 communication. Transl Res. 2021;236:117\u201332.","journal-title":"Transl Res"},{"key":"7445_CR87","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00432-024-05822-2","volume":"150","author":"M Vafaeizadeh","year":"2024","unstructured":"Vafaeizadeh M, Abroun S, Soufi Zomorrod M. Effect of human bone marrow mesenchymal stem cell-derived microvesicles on the apoptosis of the multiple myeloma cell line U266. J Cancer Res Clin Oncol. 2024;150:299.","journal-title":"J Cancer Res Clin Oncol"},{"key":"7445_CR88","doi-asserted-by":"crossref","first-page":"106566","DOI":"10.1016\/j.leukres.2021.106566","volume":"105","author":"X Tian","year":"2021","unstructured":"Tian X, Sun M, Wu H, Chen C, Li H, Qiu S, et al. Exosome-derived miR-let-7c promotes angiogenesis in multiple myeloma by polarizing M2 macrophages in the bone marrow microenvironment. Leuk Res. 2021;105:106566.","journal-title":"Leuk Res"},{"key":"7445_CR89","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1158\/1078-0432.CCR-18-2363","volume":"25","author":"H Xu","year":"2019","unstructured":"Xu H, Han H, Song S, Yi N, Qian C, Qiu Y, et al. Exosome-transmitted PSMA3 and PSMA3-AS1 promote proteasome inhibitor resistance in multiple myeloma. Clin Cancer Res. 2019;25:1923\u201335.","journal-title":"Clin Cancer Res"},{"key":"7445_CR90","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.1038\/s41598-023-36092-6","volume":"13","author":"S Miaomiao","year":"2023","unstructured":"Miaomiao S, Xiaoqian W, Yuwei S, Chao C, Chenbo Y, Yinghao L, et al. Cancer-associated fibroblast-derived exosome microRNA-21 promotes angiogenesis in multiple myeloma. Sci Rep. 2023;13:9671.","journal-title":"Sci Rep"},{"key":"7445_CR91","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/biomedicines11051400","volume":"11","author":"A Lamanuzzi","year":"2023","unstructured":"Lamanuzzi A, Saltarella I, Reale A, Melaccio A, Solimando AG, Altamura C, et al. Uptake-dependent and -Independent effects of Fibroblasts-derived extracellular vesicles on Bone marrow endothelial cells from patients with multiple myeloma: therapeutic and clinical implications. Biomedicines. 2023;11:1400.","journal-title":"Biomedicines"},{"key":"7445_CR92","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/path.5852","volume":"256","author":"I Saltarella","year":"2022","unstructured":"Saltarella I, Lamanuzzi A, Desantis V, Di Marzo L, Melaccio A, Curci P, et al. Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRnas. The J Pathol. 2022;256:402\u201313.","journal-title":"The J Pathol"},{"key":"7445_CR93","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13046-021-02209-w","volume":"41","author":"Z Wang","year":"2022","unstructured":"Wang Z, He J, Bach D, Huang Y, Li Z, Liu H, et al. Induction of m6A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance. J Exp Clin Cancer Res. 2022;41:4.","journal-title":"J Exp Clin Cancer Res"},{"key":"7445_CR94","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41375-023-01896-y","volume":"37","author":"F Cheng","year":"2023","unstructured":"Cheng F, Wang Z, You G, Liu Y, He J, Yang J. Osteocyte-derived exosomes confer multiple myeloma resistance to chemotherapy through acquisition of cancer stem cell-like features. Leukemia. 2023;37:1392\u201396.","journal-title":"Leukemia"},{"key":"7445_CR95","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/aps.2013.141","volume":"35","author":"Y Liu","year":"2014","unstructured":"Liu Y, Zhu X, Zeng C, Wu P, Wang H, Chen Z, et al. Microvesicles secreted from human multiple myeloma cells promote angiogenesis. Acta Pharmacol Sin. 2014;35:230\u201338.","journal-title":"Acta Pharmacol Sin"},{"key":"7445_CR96","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41408-018-0139-7","volume":"8","author":"S Faict","year":"2018","unstructured":"Faict S, Muller J, De Veirman K, De Bruyne E, Maes K, Vrancken L, et al. Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts. Blood Cancer J. 2018;8:105.","journal-title":"Blood Cancer J"},{"key":"7445_CR97","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7150\/thno.27550","volume":"9","author":"L Zhang","year":"2019","unstructured":"Zhang L, Lei Q, Wang H, Xu C, Liu T, Kong F, et al. Tumor-derived extracellular vesicles inhibit osteogenesis and exacerbate myeloma bone disease. Theranostics. 2019;9:196\u2013209.","journal-title":"Theranostics"},{"key":"7445_CR98","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.3390\/cancers13122969","volume":"13","author":"T Watanabe","year":"2021","unstructured":"Watanabe T. Realization of Osteolysis, angiogenesis, immunosuppression, and drug resistance by extracellular vesicles: roles of RNAs and proteins in their cargoes and of ectonucleotidases of the immunosuppressive adenosinergic noncanonical pathway in the bone marrow niche of multiple myeloma. Cancers (basel). 2021;13:2969.","journal-title":"Cancers (Basel)"},{"key":"7445_CR99","doi-asserted-by":"crossref","first-page":"60698","DOI":"10.18632\/oncotarget.10849","volume":"7","author":"L Di Marzo","year":"2016","unstructured":"Di Marzo L, Desantis V, Solimando AG, Ruggieri S, Annese T, Nico B, et al. Microenvironment drug resistance in multiple myeloma: emerging new players. Oncotarget. 2016;7:60698\u2013711.","journal-title":"Oncotarget"},{"key":"7445_CR100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/jcm7030055","volume":"7","author":"T Yamamoto","year":"2018","unstructured":"Yamamoto T, Kosaka N, Hattori Y, Ochiya T. A challenge to aging society by microRNA in extracellular vesicles: microRNA in extracellular vesicles as promising biomarkers and novel therapeutic targets in multiple myeloma. J Clin Med. 2018;7:55.","journal-title":"J Clin Med"},{"key":"7445_CR101","doi-asserted-by":"crossref","first-page":"15729","DOI":"10.1038\/ncomms15728","volume":"8","author":"M Takasugi","year":"2017","unstructured":"Takasugi M, Okada R, Takahashi A, Virya Chen D, Watanabe S, Hara E. Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2. Nat Commun. 2017;8:15729.","journal-title":"Nat Commun"},{"key":"7445_CR102","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.3390\/cancers12082167","volume":"12","author":"L Raimondi","year":"2020","unstructured":"Raimondi L, De Luca A, Fontana S, Amodio N, Costa V, Carina V, et al. Multiple myeloma-derived extracellular vesicles induce osteoclastogenesis through the activation of the XBP1\/IRE1\u03b1 Axis. Cancers (Basel). 2020;12:2167.","journal-title":"Cancers (Basel)"},{"key":"7445_CR103","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/leu.2013.231","volume":"28","author":"J Minami","year":"2014","unstructured":"Minami J, Suzuki R, Mazitschek R, Gorgun G, Ghosh B, Cirstea D, et al. Histone deacetylase 3 as a novel therapeutic target in multiple myeloma. Leukemia. 2014;28:680\u201389.","journal-title":"Leukemia"},{"key":"7445_CR104","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41375-019-0493-x","volume":"34","author":"M Ho","year":"2020","unstructured":"Ho M, Chen T, Liu J, Dowling P, Hideshima T, Zhang L, et al. Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signaling. Leukemia. 2020;34:196\u2013209.","journal-title":"Leukemia"},{"key":"7445_CR105","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.3390\/cancers13133213","volume":"13","author":"C Botta","year":"2021","unstructured":"Botta C, Mendicino F, Martino EA, Vigna E, Ronchetti D, Correale P, et al. Mechanisms of immune evasion in multiple myeloma: open questions and therapeutic opportunities. Cancers (Basel). 2021;13:3213.","journal-title":"Cancers (Basel)"},{"key":"7445_CR106","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","volume":"18","author":"L Chiossone","year":"2018","unstructured":"Chiossone L, Dumas P-Y, Vienne M, Vivier E. Natural killer cells and other innate lymphoid cells in cancer. Nat Rev Immunol. 2018;18:671\u201388.","journal-title":"Nat Rev Immunol"},{"key":"7445_CR107","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/cancers13020226","volume":"13","author":"T Pazina","year":"2021","unstructured":"Pazina T, MacFarlane AW, Bernabei L, Dulaimi E, Kotcher R, Yam C, et al. Alterations of nk cell phenotype in the disease course of multiple myeloma. Cancers (Basel). 2021;13:226.","journal-title":"Cancers (Basel)"},{"key":"7445_CR108","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/leu.2012.113","volume":"26","author":"E Van Valckenborgh","year":"2012","unstructured":"Van Valckenborgh E, Schouppe E, Movahedi K, De Bruyne E, Menu E, De Baetselier P, et al. Multiple myeloma induces the immunosuppressive capacity of distinct myeloid-derived suppressor cell subpopulations in the bone marrow. Leukemia. 2012;26:2424\u201328.","journal-title":"Leukemia"},{"key":"7445_CR109","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1517\/14712598.2013.799130","volume":"13","author":"M Rossi","year":"2013","unstructured":"Rossi M, Botta C, Correale P, Tassone P, Tagliaferri P. Immunologic microenvironment and personalized treatment in multiple myeloma. Expert Opin Biol Ther. 2013;13:S83\u201393.","journal-title":"Expert Opin Biol Ther"},{"key":"7445_CR110","doi-asserted-by":"crossref","unstructured":"Matchett EC, Kornbluth J. Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma. Front Immunol. 2023;14.","DOI":"10.3389\/fimmu.2023.1265101"},{"key":"7445_CR111","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1182\/bloodadvances.2021005772","volume":"6","author":"T Yamamoto","year":"2022","unstructured":"Yamamoto T, Nakayama J, Yamamoto Y, Kuroda M, Hattori Y, Ochiya T. SORT1\/LAMP2-mediated extracellular vesicle secretion and cell adhesion are linked to lenalidomide resistance in multiple myeloma. Blood Adv. 2022;6:2480\u201395.","journal-title":"Blood Adv"},{"issue":"Supplement 1","key":"7445_CR112","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood-2023-185134","volume":"142","author":"I Azaman","year":"2023","unstructured":"Azaman I, Chng W-J, Mustafa N, De Mel S. Extracellular vesicles secreted from Daratumumab resistant cells promote Resistance and proliferation of Daratumumab sensitive cells, possibly through the transfer of miRNA cargo. Blood. 2023;142(Supplement 1):1443\u20131443.","journal-title":"Blood"},{"key":"7445_CR113","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/cbin.11540","volume":"45","author":"J Tang","year":"2021","unstructured":"Tang J, Chen Q, Li Q, He Y, Xiao D. Exosomal mRNAs and lncRnas involved in multiple myeloma resistance to bortezomib. Cell Biol Int. 2021;45:965\u201375.","journal-title":"Cell Biol Int"},{"key":"7445_CR114","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/bjh.17329","volume":"193","author":"F Malavasi","year":"2021","unstructured":"Malavasi F, Faini AC, Morandi F, Castella B, Incarnato D, Oliviero S, et al. Molecular dynamics of targeting CD38 in multiple myeloma. Br J Haematol. 2021;193:581\u201391.","journal-title":"Br J Haematol"},{"key":"7445_CR115","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.7150\/thno.47996","volume":"11","author":"C Tu","year":"2021","unstructured":"Tu C, Du Z, Zhang H, Feng Y, Qi Y, Zheng Y, et al. Endocytic pathway inhibition attenuates extracellular vesicle-induced reduction of chemosensitivity to bortezomib in multiple myeloma cells. Theranostics. 2021;11:2364\u201380.","journal-title":"Theranostics"},{"key":"7445_CR116","doi-asserted-by":"crossref","first-page":"215649","DOI":"10.1016\/j.canlet.2022.215649","volume":"535","author":"F Wang","year":"2022","unstructured":"Wang F, Oudaert I, Tu C, Maes A, Van der Vreken A, Vlummens P, et al. System Xc\u2212 inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance. Cancer Lett. 2022;535:215649.","journal-title":"Cancer Lett"},{"key":"7445_CR117","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3324\/haematol.2018.189159","volume":"103","author":"J Caers","year":"2018","unstructured":"Caers J, Garderet L, Kort\u00fcm KM, O\u2019Dwyer ME, van de Donk NWCJ, Binder M, et al. European myeloma network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when. Haematologica. 2018;103:1772\u201384.","journal-title":"Haematologica"},{"key":"7445_CR118","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.2147\/OTT.S122241","volume":"9","author":"MM Dupuis","year":"2016","unstructured":"Dupuis MM, Tuchman SA. Non-secretory multiple myeloma: from biology to clinical management. Onco Targets Ther. 2016;9:7583\u201390.","journal-title":"Onco Targets Ther"},{"key":"7445_CR119","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/antib13010019","volume":"13","author":"HV Giles","year":"2024","unstructured":"Giles HV, Karunanithi K. Performance characteristics and limitations of the available assays for the detection and quantitation of monoclonal free light chains and new emerging methodologies. Antibodies. 2024;13:19.","journal-title":"Antibodies"},{"key":"7445_CR120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41467-017-00296-y","volume":"8","author":"L Rasche","year":"2017","unstructured":"Rasche L, Chavan SS, Stephens OW, Patel PH, Tytarenko R, Ashby C, et al. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing. Nat Commun. 2017;8:268.","journal-title":"Nat Commun"},{"key":"7445_CR121","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.3390\/ijms25105208","volume":"25","author":"R Heestermans","year":"2024","unstructured":"Heestermans R, Schots R, De Becker A, Van Riet I. Liquid biopsies as non-invasive tools for mutation profiling in multiple myeloma: application potential, challenges, and opportunities. Int J Mol Sci. 2024;25:5208.","journal-title":"Int J Mol Sci"},{"key":"7445_CR122","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.3390\/cancers13153827","volume":"13","author":"JY Hur","year":"2021","unstructured":"Hur JY, Lee KY. Characteristics and clinical application of extracellular vesicle-derived dna. Cancers (Basel). 2021;13:3827.","journal-title":"Cancers (Basel)"},{"key":"7445_CR123","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1007\/s13277-015-3741-3","volume":"36","author":"A Caivano","year":"2015","unstructured":"Caivano A, Laurenzana I, De Luca L, La Rocca F, Simeon V, Trino S, et al. High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumor Biol. 2015;36:9739\u201352.","journal-title":"Tumor Biol"},{"key":"7445_CR124","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neo.2015.11.011","volume":"18","author":"SR Krishnan","year":"2016","unstructured":"Krishnan SR, Luk F, Brown RD, Suen H, Kwan Y, Bebawy M. Isolation of human CD138+ microparticles from the plasma of patients with multiple myeloma. Neoplasia. 2016;18:25\u201332.","journal-title":"Neoplasia"},{"key":"7445_CR125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41408-020-0304-7","volume":"10","author":"S Rajeev Krishnan","year":"2020","unstructured":"Rajeev Krishnan S, De Rubis G, Suen H, Joshua D, Lam Kwan Y, Bebawy M. A liquid biopsy to detect multidrug resistance and disease burden in multiple myeloma. Blood Cancer J. 2020;10:37.","journal-title":"Blood Cancer J"},{"key":"7445_CR126","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jprot.2015.12.016","volume":"136","author":"SW Harshman","year":"2016","unstructured":"Harshman SW, Canella A, Ciarlariello PD, Agarwal K, Branson OE, Rocci A, et al. Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers. J Proteomics. 2016;136:89\u201398.","journal-title":"J Proteomics"},{"key":"7445_CR127","doi-asserted-by":"crossref","unstructured":"Ferreira BV, Carneiro EA, Pestana C, Barahona F, Caetano J, Lopes R, et al. Patient-derived extracellular vesicles proteins as new biomarkers in multiple myeloma - a real-world study. Front Oncol. 2022;12.","DOI":"10.3389\/fonc.2022.860849"},{"key":"7445_CR128","doi-asserted-by":"crossref","first-page":"13686","DOI":"10.3390\/ijms232213686","volume":"23","author":"R Bergantim","year":"2022","unstructured":"Bergantim R, Peixoto da Silva S, Pol\u00f3nia B, Barbosa MAG, Albergaria A, Lima J, et al. Detection of measurable residual disease biomarkers in extracellular vesicles from liquid biopsies of multiple myeloma patients\u2014A proof of concept. Int J Mol Sci. 2022;23:13686.","journal-title":"Int J Mol Sci"},{"key":"7445_CR129","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood-2016-09-742296","volume":"129","author":"S Manier","year":"2017","unstructured":"Manier S, Liu C-J, Avet-Loiseau H, Park J, Shi J, Campigotto F, et al. Prognostic role of circulating exosomal miRnas in multiple myeloma. Blood. 2017;129:2429\u201336.","journal-title":"Blood"},{"key":"7445_CR130","first-page":"1","volume":"2019","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Li Y, Geng C, Wang H, Chen W. Potential relationship between clinical significance and serum exosomal miRnas in patients with multiple myeloma. Biomed Res Int. 2019;2019:1\u20138.","journal-title":"Biomed Res Int"},{"key":"7445_CR131","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hon.2639","volume":"37","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Li Y, Geng C, Zhou H, Gao W, Chen W. Serum exosomal microRNAs as novel biomarkers for multiple myeloma. Hematol Oncol. 2019;37:409\u201317.","journal-title":"Hematol Oncol"},{"key":"7445_CR132","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/03936155241283747","volume":"39","author":"J Zhang","year":"2024","unstructured":"Zhang J, Luo C, Long H, Zhang B, Shan H, Hou B. Circulating exosomal miRNA-451 as an effective diagnostic biomarker and prognostic indicator for multiple myeloma. Int J Biol Markers. 2024;39:301\u201309.","journal-title":"Int J Biol Markers"},{"key":"7445_CR133","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13046-022-02276-7","volume":"41","author":"X Tang","year":"2022","unstructured":"Tang X, Deng Z, Ding P, Qiang W, Lu Y, Gao S, et al. A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing. J Exp Clin Cancer Res. 2022;41:85.","journal-title":"J Exp Clin Cancer Res"},{"key":"7445_CR134","doi-asserted-by":"crossref","unstructured":"Reale A, Khong T, Xu R, Chen M, Mithraprabhu S, Bingham N, et al. Human plasma extracellular vesicle isolation and proteomic characterization for the optimization of liquid biopsy in multiple myeloma. 2021;151\u201391.","DOI":"10.1007\/978-1-0716-1186-9_10"},{"key":"7445_CR135","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1021\/acsnano.4c16353","volume":"19","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Qin X, Xu Z, Liu W, Lu H, Yang Y, et al. Electric Field-resistant bubble-enhanced Wash-free profiling of extracellular vesicle surface markers. ACS Nano. 2025;19:8093\u2013107.","journal-title":"ACS Nano"},{"key":"7445_CR136","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1021\/acs.jproteome.5c00149","volume":"24","author":"PS Suresh","year":"2025","unstructured":"Suresh PS, Zhang Q. Comprehensive comparison of methods for isolation of extracellular vesicles from human plasma. J Proteome Res. 2025;24:2956\u201367.","journal-title":"J Proteome Res"},{"key":"7445_CR137","doi-asserted-by":"crossref","unstructured":"Hu L, Zheng X, Zhou M, Wang J, Tong L, Dong M, et al. Optimized AF4 combined with density cushion ultracentrifugation enables profiling of high-purity human blood extracellular vesicles. J Extracell Vesicles. 2024;13.","DOI":"10.1002\/jev2.12470"},{"key":"7445_CR138","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1021\/acs.analchem.4c06105","volume":"97","author":"MS Gerlt","year":"2025","unstructured":"Gerlt MS, Laurell T. Acoustofluidic chromatography for extracellular vesicle enrichment from 4 \u03bcL blood plasma samples. Anal Chem. 2025;97:6049\u201358.","journal-title":"Anal Chem"},{"key":"7445_CR139","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1039\/D4LC00830H","volume":"25","author":"S Yaman","year":"2025","unstructured":"Yaman S, Devoe T, Aygun U, Parlatan U, Bobbili MR, Karim AH, et al. EV-Lev: extracellular vesicle isolation from human plasma using microfluidic magnetic levitation device. Lab Chip. 2025;25:1439\u201351.","journal-title":"Lab Chip"},{"key":"7445_CR140","doi-asserted-by":"crossref","unstructured":"Meng Y, Zhang Y, B\u00fchler M, Wang S, Asghari M, St\u00fcrchler A, et al. Direct isolation of small extracellular vesicles from human blood using viscoelastic microfluidics. Sci Adv. 2023;9.","DOI":"10.1126\/sciadv.adi5296"},{"key":"7445_CR141","doi-asserted-by":"crossref","unstructured":"Li Z, Liu C, Cheng Y, Li Y, Deng J, Bai L, et al. Cascaded microfluidic circuits for pulsatile filtration of extracellular vesicles from whole blood for early cancer diagnosis. Sci Adv. 2023;9.","DOI":"10.1126\/sciadv.ade2819"},{"key":"7445_CR142","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3324\/haematol.2020.247015","volume":"105","author":"A Gulla","year":"2020","unstructured":"Gulla A, Anderson KC. Multiple myeloma: the (r)evolution of current therapy and a glance into future. Haematologica. 2020;105:2358\u201367.","journal-title":"Haematologica"},{"key":"7445_CR143","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.3390\/cancers12113106","volume":"12","author":"F Bonello","year":"2020","unstructured":"Bonello F, Boccadoro M, Larocca A. Diagnostic and therapeutic challenges in the management of intermediate and frail elderly multiple myeloma patients. Cancers (Basel). 2020;12:3106.","journal-title":"Cancers (Basel)"},{"key":"7445_CR144","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1182\/blood.2023021523","volume":"142","author":"MK Samur","year":"2023","unstructured":"Samur MK. Myeloma heterogeneity at cell resolution. Blood. 2023;142:1582\u201383.","journal-title":"Blood"},{"key":"7445_CR145","doi-asserted-by":"crossref","unstructured":"Chen T, Moscvin M, Bianchi G. Exosomes in the pathogenesis and treatment of multiple myeloma in the context of the bone marrow microenvironment. Front Oncol. 2020;10.","DOI":"10.3389\/fonc.2020.608815"},{"key":"7445_CR146","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhang H, Gu J, Zhang J, Shi H, Qian H, et al. Engineered extracellular vesicles for cancer therapy. Adv Mater. 2021;33.","DOI":"10.1002\/adma.202005709"},{"key":"7445_CR147","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205565","author":"B Fan","year":"2024","unstructured":"Fan B, Wang L, Wang J. RAB22A as a predictor of exosome secretion in the progression and relapse of multiple myeloma. Aging (Albany NY). 2024. https:\/\/doi.org\/10.18632\/aging.205565.","journal-title":"Aging (Albany NY)"},{"key":"7445_CR148","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1158\/1078-0432.CCR-15-2170","volume":"22","author":"L Rivoltini","year":"2016","unstructured":"Rivoltini L, Chiodoni C, Squarcina P, Tortoreto M, Villa A, Vergani B, et al. TNF-Related apoptosis-inducing ligand (TRAIL)\u2013armed exosomes deliver proapoptotic signals to tumor site. Clin Cancer Res. 2016;22:3499\u2013512.","journal-title":"Clin Cancer Res"},{"key":"7445_CR149","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.actbio.2022.02.028","volume":"143","author":"C He","year":"2022","unstructured":"He C, Zhang M, Liu L, Han Y, Xu Z, Xiong Y, et al. Cellular membrane-based vesicles displaying a reconstructed B cell maturation antigen for multiple myeloma therapy by dual targeting APRIL and BAFF. Acta Biomater. 2022;143:406\u201317.","journal-title":"Acta Biomater"},{"key":"7445_CR150","doi-asserted-by":"crossref","unstructured":"Soma E, Yamayoshi A, Toda Y, Mishima Y, Hosogi S, Ashihara E. Successful incorporation of exosome-capturing antibody-siRNA complexes into multiple myeloma cells and suppression of targeted mRNA transcripts. Cancers (Basel). 2022;14.","DOI":"10.3390\/cancers14030566"},{"key":"7445_CR151","doi-asserted-by":"crossref","first-page":"e2301748","DOI":"10.1002\/smll.202301748","volume":"19","author":"Z Cao","year":"2023","unstructured":"Cao Z, Li P, Li Y, Zhang M, Hao M, Li W, et al. Encapsulation of Nano-Bortezomib in apoptotic stem cell-derived vesicles for the treatment of multiple myeloma. Small. 2023;19:e2301748.","journal-title":"Small"},{"key":"7445_CR152","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1182\/bloodadvances.2023012464","volume":"8","author":"S Yuan","year":"2024","unstructured":"Yuan S, Li Q, He C, Bing M, Zhang X, Xu H, et al. Anti-BCMA\u2013engineered exosomes for bortezomib-targeted delivery in multiple myeloma. Blood Adv. 2024;8:4886\u201399.","journal-title":"Blood Adv"},{"key":"7445_CR153","doi-asserted-by":"crossref","unstructured":"Cao Y, Hu X, Wu D, Jiang Y, Yu Y, Wang S, et al. Targeting capacity, safety and efficacy of engineered extracellular vesicles delivered by transdermal microneedles to treat plasmacytoma in mice. Clin Transl Med. 2025;15.","DOI":"10.1002\/ctm2.70327"},{"key":"7445_CR154","doi-asserted-by":"crossref","first-page":"216989","DOI":"10.1016\/j.canlet.2024.216989","volume":"595","author":"G Zhao","year":"2024","unstructured":"Zhao G, Wang Y, Xing S, Jiang Y, Ding J, Cai Y, et al. Exosome-based anticancer vaccines: from bench to bedside. Cancer Lett. 2024;595:216989.","journal-title":"Cancer Lett"},{"key":"7445_CR155","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1111\/j.1582-4934.2009.00851.x","volume":"14","author":"Y Xie","year":"2010","unstructured":"Xie Y, Bai O, Zhang H, Yuan J, Zong S, Chibbar R, et al. Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8 + ctl- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70. J Cell Mol Med. 2010;14:2655\u201366.","journal-title":"J Cell Mol Med"},{"key":"7445_CR156","doi-asserted-by":"crossref","first-page":"e1027472","DOI":"10.1080\/2162402X.2015.1027472","volume":"4","author":"Y Liu","year":"2015","unstructured":"Liu Y, Gu Y, Cao X. The exosomes in tumor immunity. Oncoimmunology. 2015;4:e1027472.","journal-title":"Oncoimmunology"},{"key":"7445_CR157","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/s12276-025-01506-0","volume":"57","author":"X Yu","year":"2025","unstructured":"Yu X, Ding P, Guo M, Tang X, Wang Z, Zhang Y, et al. Extracellular vesicle-mediated delivery of circp53 suppresses the progression of multiple cancers by activating the CypD\/TRAP\/HSP90 pathway. Exp Mol Med. 2025;57:1711\u201326.","journal-title":"Exp Mol Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07445-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07445-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07445-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:01:58Z","timestamp":1767474118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07445-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":157,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7445"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07445-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}